Cambria Investment Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.1M Buy
1,102,545
+167,486
+18% +$1.87M 0.5% 41
2026
Q1
$10.1M Sell
935,059
-487,152
-34% -$4.17M 0.57% 29
2025
Q4
$8.69M Buy
+1,422,211
New +$8.49M 0.51% 61
2023
Q1
– Sell
-89,648
Closed -$1.51M – 296
2022
Q4
$1.51M Buy
89,648
+34,480
+63% +$569K 0.13% 141
2022
Q3
$644K Buy
55,168
+34,588
+168% +$494K 0.07% 166
2022
Q2
$324K Sell
20,580
-5,270
-20% -$88.5K 0.04% 188
2022
Q1
$400K Buy
25,850
+3,525
+16% +$44.5K 0.05% 165
2021
Q4
$189K Hold
22,325
– – 0.03% 255
2021
Q3
$201K Hold
22,325
– – 0.04% 230
2021
Q2
$222K Buy
22,325
+3,525
+19% +$29.8K 0.04% 199
2021
Q1
$134K Buy
+18,800
New +$132K 0.03% 213

Other funds holding PTEN

Cambria Investment Management's PTEN Position: Q2 2026 in Review

Cambria Investment Management increased its Patterson-UTI (PTEN) stake by 18% in Q2 2026, buying an estimated $1.87M and bringing the position to 1,102,545 shares worth $10.1M. The position accounts for 0.5% of the portfolio, ranked #41.

Cambria Investment Management first reported a position in PTEN in Q1 2021 and has held it in 11 quarters since. The position peaked at $10.1M in Q1 2026. 439 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Cambria Investment Management held 1,102,545 shares of Patterson-UTI worth $10.1M as of Q2 2026.
  • Cambria Investment Management bought 167,486 Patterson-UTI shares in Q2 2026, an estimated $1.87M.
  • Patterson-UTI made up 0.5% of Cambria Investment Management's portfolio in Q2 2026, its #41 holding.
  • Cambria Investment Management first reported a position in Patterson-UTI in Q1 2021 and has held it in 11 quarters since.
  • Cambria Investment Management's Patterson-UTI position peaked at $10.1M in Q1 2026.
  • 439 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Cambria Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.